Rani Therapeutics (RANI) insider Imran Mir A buys 36,000 shares
Rhea-AI Filing Summary
Imran Mir A, a director and 10% owner of Rani Therapeutics Holdings, Inc., purchased 36,000 shares of Class A Common Stock on July 21, 2026 at a weighted average price of about $0.69 per share, in multiple transactions between $0.688 and $0.69. After this purchase, he directly holds 2,119,334 Class A shares and has indirect interests in 74,139 Class A and 22,660,053 Class B shares through affiliated entities, for which he disclaims beneficial ownership beyond his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 36,000 shares
Net Buy
3 txns
Insider
IMRAN MIR A
Role
Director, 10% Owner
Bought
36,000 shs ($25K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Class A Common Stock F1 | 36,000 | $0.69 | $25K |
| holding | Class A Common Stock F2 | -- | -- | -- |
| holding | Class B Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 2,119,334 shares (Direct);
Class A Common Stock — 74,139 shares (Indirect, See footnote);
Class B Common Stock — 22,660,053 shares (Indirect, See footnote)
Footnotes (3)
- F1. The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.688 to $0.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F2. The Reporting Person is a General Partner of InCube Ventures II, L.P. and Rani Investment Corp. InCube Labs, L.L.C. is wholly-owned by the Reporting Person and his family. Represents 52,781 shares of Class A Common Stock of the Issuer held by InCube Ventures II, L.P., 13,664 shares of Class A Common Stock of the Issuer held by InCube Labs, L.L.C., and 7,694 Class A Shares held by Rani Investment Corp. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- F3. The Reporting Person is a General Partner of InCube Ventures II, L.P., and InCube Labs, LLC is wholly-owned by the Reporting Person and his family. Represents 22,411,124 Class B Shares held by InCube Labs, LLC and 248,929 Class B Shares held by InCube Ventures II, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
Key Figures
Shares purchased: 36,000 shares of Class A Common Stock
Weighted average purchase price: $0.69 per share
Direct Class A holdings after transaction: 2,119,334 shares
+3 more
6 metrics
Shares purchased
36,000 shares of Class A Common Stock
Non-derivative purchase on July 21, 2026
Weighted average purchase price
$0.69 per share
Class A purchase, trades between $0.688 and $0.69
Direct Class A holdings after transaction
2,119,334 shares
Total Class A Common Stock directly held following purchase
Indirect Class A holdings
74,139 shares
Class A Common Stock held via InCube Ventures II, L.P., InCube Labs, L.L.C., and Rani Investment Corp.
Indirect Class B holdings
22,660,053 shares
Class B Common Stock held via InCube Labs, LLC and InCube Ventures II, L.P.
Net share direction
36,000 net buy shares
transactionSummary reports net-buy direction for this filing
Key Terms
weighted average price, beneficial ownership, pecuniary interest, General Partner
4 terms
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of these securities..."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of his pecuniary interest therein."
General Partner financial
"The Reporting Person is a General Partner of InCube Ventures II, L.P."
A general partner is the person or firm that runs an investment partnership and legally represents it — they make the day-to-day decisions, choose which assets to buy or sell, and are responsible for the partnership’s obligations. Investors care because the general partner’s judgment, risk-taking and fee and profit-sharing arrangements determine both the potential returns and the level of exposure to losses; think of the GP as the ship’s captain whose skill and honesty shape the voyage’s outcome.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did insider Imran Mir A report in the latest RANI Form 4?
Imran Mir A reported buying 36,000 Rani Therapeutics Class A shares on July 21, 2026 at a weighted average price of about $0.69 per share, increasing his directly held Class A position to 2,119,334 shares and updating his indirect holdings.
How are Imran Mir A’s indirect RANI holdings structured?
Indirect Class A holdings of 74,139 shares are held via InCube Ventures II, L.P., InCube Labs, L.L.C., and Rani Investment Corp. Indirect Class B holdings of 22,660,053 shares are held mainly by InCube Labs, LLC and InCube Ventures II, L.P., subject to pecuniary-interest disclaimers.